These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24516913)

  • 21. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
    Zeremski M; Martinez AD; Talal AH
    Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
    [No Abstract]   [Full Text] [Related]  

  • 23. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
    Corales RB; Djeloski DS; Mancenido MD; Valenti WM
    AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis drug reduces effects of HIV medications.
    Kuehn BM
    JAMA; 2012 May; 307(20):2138. PubMed ID: 22618906
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C and B viruses: the new opportunists in HIV infection.
    Chung RT
    Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focus on hepatitis. Glimpses of hope on a distant horizon.
    Raymond D
    IAPAC Mon; 2004 Aug; 10(8):300-1. PubMed ID: 15719462
    [No Abstract]   [Full Text] [Related]  

  • 29. Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals.
    Hasson H; Merli M; Messina E; Bhoori S; Salpietro S; Morsica G; Regalia E; Bagaglio S; Lazzarin A; Uberti-Foppa C; Mazzaferro V
    J Hepatol; 2017 Aug; 67(2):415-417. PubMed ID: 28411040
    [No Abstract]   [Full Text] [Related]  

  • 30. Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus-coinfected patient with cure of hepatitis C by direct-acting antiviral agents.
    Mauge L; Pavie J; Batisse D; Darnige L
    Hepatology; 2018 Feb; 67(2):794-796. PubMed ID: 28960371
    [No Abstract]   [Full Text] [Related]  

  • 31. Co-infection with HIV and hepatitis C: an overview.
    Newcomb-Fernandez J
    Res Initiat Treat Action; 2004; 10(2):5-16. PubMed ID: 15828095
    [No Abstract]   [Full Text] [Related]  

  • 32. New promises for hepatitis C cure in HIV coinfection.
    Labarga P
    AIDS Rev; 2014; 16(1):52-3. PubMed ID: 24589972
    [No Abstract]   [Full Text] [Related]  

  • 33. Report from the 14th Retrovirus Conference. New data on HIV and viral hepatitis coinfection.
    Albrecht H
    AIDS Clin Care; 2007 May; 19(5):41. PubMed ID: 18398990
    [No Abstract]   [Full Text] [Related]  

  • 34. HCV/HIV-coinfection--is there a state of the art after APRICOT and RIBAVIC?
    Mauss S; Rockstroh JK
    J Antimicrob Chemother; 2005 Oct; 56(4):615-8. PubMed ID: 16115826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C Direct Acting Antiviral Therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and Barriers.
    Kuniholm MH; Leach T; Lunievicz J; Olivo N; Anastos K; Vazquez Y; Brennan-Ing M; Karpiak SE; Alao O; Nash D; Ernst J
    AIDS Patient Care STDS; 2015 Dec; 29(12):643-5. PubMed ID: 26669792
    [No Abstract]   [Full Text] [Related]  

  • 36. Time-dependent bias in hepatitis C classification.
    Gillis J; Cooper C; Burchell AN; Gardner S; Manno M; Mazzulli T; Rourke SB; Raboud JM;
    Epidemiology; 2015 Mar; 26(2):e24-6. PubMed ID: 25643117
    [No Abstract]   [Full Text] [Related]  

  • 37. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.
    Kim AY; Chung RT; Polsky B
    AIDS Clin Rev; 2000-2001; ():263-306. PubMed ID: 10999223
    [No Abstract]   [Full Text] [Related]  

  • 38. Current challenges in hepatitis C.
    Swan T
    Res Initiat Treat Action; 2004; 10(2):17-20. PubMed ID: 15828096
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatitis C virus infection alone or associated with human immunodeficiency virus infection: comparison of two recent French survey].
    Cacoub P; Rosenthal E
    Rev Med Interne; 2012 Jul; 33(7):355-7. PubMed ID: 22280851
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M; Salmon-Céron D; Dabis F; Chêne G
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.